<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40262961</PMID><DateCompleted><Year>2025</Year><Month>04</Month><Day>23</Day></DateCompleted><DateRevised><Year>2025</Year><Month>04</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2044-6055</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>4</Issue><PubDate><Year>2025</Year><Month>Apr</Month><Day>22</Day></PubDate></JournalIssue><Title>BMJ open</Title><ISOAbbreviation>BMJ Open</ISOAbbreviation></Journal><ArticleTitle>Effects of Spirulina platensis supplementation on quality of life, severity of disease and serum total antioxidant capacity, malondialdehyde and zonulin in constipation-predominant irritable bowel syndrome: protocol for a randomised, double-blinded, placebo-controlled clinical trial from Iran.</ArticleTitle><Pagination><StartPage>e086521</StartPage><MedlinePgn>e086521</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e086521</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjopen-2024-086521</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Irritable bowel syndrome (IBS) is one of the most common chronic gut-brain interaction disorders. Nevertheless, there is currently no treatment for IBS. Low-grade inflammation and oxidative stress are contributing factors to the increased perception of abdominal pain and heightened sensitivity of the nervous system in these patients. Spirulina platensis is a rich source of essential nutrients, including amino acids, vitamins, minerals, phytochemicals, essential fatty acids and fibre. It has been found that Spirulina possesses a variety of therapeutic properties such as antioxidant, anti-inflammatory and antidepressant effects, which may be advantageous in reducing complications of IBS. The aim of present randomised clinical trial (RCT) is to assess the efficacy of Spirulina supplementation on IBS.</AbstractText><AbstractText Label="METHODS AND ANALYSIS" NlmCategory="METHODS">This study is a 12-week, 1:1 parallel-group, double-blinded, randomised controlled trial. Sixty adult individuals diagnosed with IBS according to the Rome IV criteria will be randomised to consume either Spirulina capsules (500 mg) or a placebo, two times a day. The primary outcomes of this RCT are the changes in the IBS quality of life, severity of IBS symptoms, and gut permeability from baseline to 12 weeks of the intervention. The secondary outcomes are the changes in the serum total antioxidant capacity and serum malondialdehyde from baseline to the end of intervention. If this RCT demonstrates significant results in gut permeability, antioxidant status and reduction in IBS symptoms, it could support the use of Spirulina in managing IBS and could potentially reduce healthcare costs.</AbstractText><AbstractText Label="ETHICS AND DISSEMINATION" NlmCategory="BACKGROUND">The study protocol has been approved by the Medical Ethics Committee of Isfahan University of Medical Sciences, Isfahan, Iran (ID: IR.MUI.</AbstractText><AbstractText Label="RESEARCH" NlmCategory="METHODS">REC.1401.370). Findings will be presented in subsequent publications.</AbstractText><AbstractText Label="TRIAL REGISTRATION NUMBER" NlmCategory="BACKGROUND">IRCT20140208016529N8; Iranian Registry of Clinical Trials; registered on 25 April 2023.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jafari Nasab</LastName><ForeName>Saeede</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Clinical Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hajihashemi</LastName><ForeName>Parisa</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Isfahan Gastroenterology and Hepatology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feizi</LastName><ForeName>Awat</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1930-0340</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shahoon</LastName><ForeName>Hassan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Isfahan Gastroenterology and Hepatology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ani</LastName><ForeName>Alireza</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Bioinformatics, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roohafza</LastName><ForeName>Hamidreza</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Cardiac Rehabilitation Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adibi</LastName><ForeName>Peyman</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Isfahan Gastroenterology and Hepatology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Entezari</LastName><ForeName>Mohammdanhasan</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-4321-4124</Identifier><AffiliationInfo><Affiliation>Department of Clinical Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bagherniya</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5861-6129</Identifier><AffiliationInfo><Affiliation>Department of Community Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran bagherniya@yahoo.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078325">Clinical Trial Protocol</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>04</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open</MedlineTA><NlmUniqueID>101552874</NlmUniqueID><ISSNLinking>2044-6055</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000975">Antioxidants</NameOfSubstance></Chemical><Chemical><RegistryNumber>4Y8F71G49Q</RegistryNumber><NameOfSubstance UI="D008315">Malondialdehyde</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011498">Protein Precursors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C408043">zonulin</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Organism" UI="C000651671">Arthrospira platensis</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000975" MajorTopicYN="Y">Antioxidants</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003248" MajorTopicYN="Y">Constipation</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019587" MajorTopicYN="Y">Dietary Supplements</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007492" MajorTopicYN="N" Type="Geographic">Iran</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043183" MajorTopicYN="Y">Irritable Bowel Syndrome</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008315" MajorTopicYN="Y">Malondialdehyde</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011498" MajorTopicYN="N">Protein Precursors</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053545" MajorTopicYN="Y">Spirulina</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">GASTROENTEROLOGY</Keyword><Keyword MajorTopicYN="N">Irritable Bowel Syndrome</Keyword><Keyword MajorTopicYN="N">Quality of Life</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>4</Month><Day>23</Day><Hour>6</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>4</Month><Day>23</Day><Hour>0</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>22</Day><Hour>21</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>4</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40262961</ArticleId><ArticleId IdType="pmc">PMC12015699</ArticleId><ArticleId IdType="doi">10.1136/bmjopen-2024-086521</ArticleId><ArticleId IdType="pii">bmjopen-2024-086521</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bai T, Zeng H, Long Y, et al. The efficacy of Bifidobacterium quadruple viable tablet in the treatment of diarrhea predominant irritable bowel syndrome: protocol for a randomized, double-blind, placebo-controlled, multicenter trial. Trials. 2020;21:597. doi: 10.1186/s13063-020-04490-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-020-04490-0</ArticleId><ArticleId IdType="pmc">PMC7329396</ArticleId><ArticleId IdType="pubmed">32605578</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemppinen A, Howell C, Allgar V, et al. Randomised, double-blind, placebo controlled multi-centre study to assess the efficacy, tolerability and safety of Enterosgel&#xae; in the treatment of irritable bowel syndrome with diarrhoea (IBS-D) in adults. Trials. 2020;21:122. doi: 10.1186/s13063-020-4069-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-020-4069-x</ArticleId><ArticleId IdType="pmc">PMC6993329</ArticleId><ArticleId IdType="pubmed">32000822</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbasnezhad A, Amani R, Hajiani E, et al. Effect of vitamin D on gastrointestinal symptoms and health-related quality of life in irritable bowel syndrome patients: a randomized double-blind clinical trial. Neurogastroenterol Motil. 2016;28:1533&#x2013;44. doi: 10.1111/nmo.12851.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nmo.12851</ArticleId><ArticleId IdType="pubmed">27154424</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang K-Y, Wang F-Y, Lv M, et al. Irritable bowel syndrome: Epidemiology, overlap disorders, pathophysiology and treatment. World J Gastroenterol. 2023;29:4120&#x2013;35. doi: 10.3748/wjg.v29.i26.4120.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v29.i26.4120</ArticleId><ArticleId IdType="pmc">PMC10354571</ArticleId><ArticleId IdType="pubmed">37475846</ArticleId></ArticleIdList></Reference><Reference><Citation>Mearin F, Lacy BE, Chang L, et al. Bowel Disorders. Gastroenterology. 2016:S0016-5085(16)00222-5. doi: 10.1053/j.gastro.2016.02.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2016.02.031</ArticleId><ArticleId IdType="pubmed">27144627</ArticleId></ArticleIdList></Reference><Reference><Citation>Miryan M, Soleimani D, Alavinejad P, et al. Effects of propolis supplementation on irritable bowel syndrome with constipation (IBS-C) and mixed (IBS-M) stool pattern: A randomized, double-blind clinical trial. Food Sci Nutr. 2022;10:1899&#x2013;907. doi: 10.1002/fsn3.2806.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/fsn3.2806</ArticleId><ArticleId IdType="pmc">PMC9179135</ArticleId><ArticleId IdType="pubmed">35702280</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Feng L, Wang X, et al. Low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols diet compared with traditional dietary advice for diarrhea-predominant irritable bowel syndrome: a parallel-group, randomized controlled trial with analysis of clinical and microbiological factors associated with patient outcomes. Am J Clin Nutr. 2021;113:1531&#x2013;45. doi: 10.1093/ajcn/nqab005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/nqab005</ArticleId><ArticleId IdType="pubmed">33740048</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirzaie Z, Bastani A, Haji-Aghamohammadi AA, et al. Effects of Ellagic Acid on Oxidative Stress Index, Inflammatory Markers and Quality of Life in Patients With Irritable Bowel Syndrome: Randomized Double-blind Clinical Trial. Clin Nutr Res. 2022;11:98&#x2013;109. doi: 10.7762/cnr.2022.11.2.98.</Citation><ArticleIdList><ArticleId IdType="doi">10.7762/cnr.2022.11.2.98</ArticleId><ArticleId IdType="pmc">PMC9065395</ArticleId><ArticleId IdType="pubmed">35558999</ArticleId></ArticleIdList></Reference><Reference><Citation>Balmus I-M, Ciobica A, Cojocariu R, et al. Irritable Bowel Syndrome and Neurological Deficiencies: Is There A Relationship? The Possible Relevance of the Oxidative Stress Status. Medicina (Kaunas) 2020;56:175. doi: 10.3390/medicina56040175.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina56040175</ArticleId><ArticleId IdType="pmc">PMC7230401</ArticleId><ArticleId IdType="pubmed">32295083</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirzaie Z, Bastani A, Hesami S, et al. Improving Effect of Ellagic Acid on Sleep Quality and Gastrointestinal Symptoms in Patient With Irritable Bowel Syndrome: Randomized Double-Blind Clinical Trial. Turk J Gastroenterol . 2021;32:937&#x2013;44. doi: 10.5152/tjg.2021.20344.</Citation><ArticleIdList><ArticleId IdType="doi">10.5152/tjg.2021.20344</ArticleId><ArticleId IdType="pmc">PMC8975483</ArticleId><ArticleId IdType="pubmed">34872895</ArticleId></ArticleIdList></Reference><Reference><Citation>Moradi S, Zobeiri M, Feizi A, et al. The effects of spirulina (Arthrospira platensis) supplementation on anthropometric indices, blood pressure, sleep quality, mental health, fatigue status and quality of life in patients with ulcerative colitis: A randomised, double-blinded, placebo-controlled trial. Int J Clin Pract. 2021;75:e14472. doi: 10.1111/ijcp.14472.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.14472</ArticleId><ArticleId IdType="pubmed">34107141</ArticleId></ArticleIdList></Reference><Reference><Citation>Ansari R, Foroughinia F, Dadbakhsh AH, et al. An Overview of Pharmacological and Clinical Aspects of Spirulina. Curr Drug Discov Technol. 2023;20:e291122211363. doi: 10.2174/1570163820666221129141217.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1570163820666221129141217</ArticleId><ArticleId IdType="pubmed">36453480</ArticleId></ArticleIdList></Reference><Reference><Citation>Moradi-Kor N, Ghanbari A, Rashidipour H, et al. Therapeutic Effects of Spirulina platensis Against Adolescent Stress-Induced Oxidative Stress, Brain-Derived Neurotrophic Factor Alterations and Morphological Remodeling in the Amygdala of Adult Female Rats. J Exp Pharmacol. 2020;12:75&#x2013;85. doi: 10.2147/JEP.S237378.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JEP.S237378</ArticleId><ArticleId IdType="pmc">PMC7090200</ArticleId><ArticleId IdType="pubmed">32256126</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorrenti V, Castagna DA, Fortinguerra S, et al. Spirulina Microalgae and Brain Health: A Scoping Review of Experimental and Clinical Evidence. Mar Drugs. 2021;19:293. doi: 10.3390/md19060293.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/md19060293</ArticleId><ArticleId IdType="pmc">PMC8224803</ArticleId><ArticleId IdType="pubmed">34067317</ArticleId></ArticleIdList></Reference><Reference><Citation>Demelash S. Spirulina as a main source of tryptophan for mental illness: improving level of serotonin through tryptophan supplementation. Global J Med Public Health. 2018;7:1&#x2013;5.</Citation></Reference><Reference><Citation>Mete R, Tulubas F, Oran M, et al. The role of oxidants and reactive nitrogen species in irritable bowel syndrome: a potential etiological explanation. Med Sci Monit . 2013;19:762&#x2013;6. doi: 10.12659/MSM.889068.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.889068</ArticleId><ArticleId IdType="pmc">PMC3781198</ArticleId><ArticleId IdType="pubmed">24029778</ArticleId></ArticleIdList></Reference><Reference><Citation>Keshteli AH, Dehestani B, Daghaghzadeh H, et al. Epidemiological features of irritable bowel syndrome and its subtypes among Iranian adults. Ann Gastroenterol. 2015;28:253&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4367216</ArticleId><ArticleId IdType="pubmed">25831414</ArticleId></ArticleIdList></Reference><Reference><Citation>Grymonpre RE, Didur CD, Montgomery PR, et al. Pill count, self-report, and pharmacy claims data to measure medication adherence in the elderly. Ann Pharmacother . 1998;32:749&#x2013;54. doi: 10.1345/aph.17423.</Citation><ArticleIdList><ArticleId IdType="doi">10.1345/aph.17423</ArticleId><ArticleId IdType="pubmed">9681089</ArticleId></ArticleIdList></Reference><Reference><Citation>Madden K, Scott T, McKay P, et al. Predicting and Preventing Loss to Follow-up of Adult Trauma Patients in Randomized Controlled Trials: An Example from the FLOW Trial. J Bone Joint Surg Am. 2017;99:1086&#x2013;92. doi: 10.2106/JBJS.16.00900.</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.16.00900</ArticleId><ArticleId IdType="pmc">PMC5490332</ArticleId><ArticleId IdType="pubmed">28678121</ArticleId></ArticleIdList></Reference><Reference><Citation>Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther . 1997;11:395&#x2013;402. doi: 10.1046/j.1365-2036.1997.142318000.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2036.1997.142318000.x</ArticleId><ArticleId IdType="pubmed">9146781</ArticleId></ArticleIdList></Reference><Reference><Citation>Samadi N, Mozaffari-Khosravi H, Rahmanian M, et al. Effects of bee propolis supplementation on glycemic control, lipid profile and insulin resistance indices in patients with type 2 diabetes: a randomized, double-blind clinical trial. J Integr Med. 2017;15:124&#x2013;34. doi: 10.1016/S2095-4964(17)60315-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2095-4964(17)60315-7</ArticleId><ArticleId IdType="pubmed">28285617</ArticleId></ArticleIdList></Reference><Reference><Citation>Drossman DA, Patrick DL, Whitehead WE, et al. Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire. Am J Gastroenterol. 2000;95:999&#x2013;1007. doi: 10.1111/j.1572-0241.2000.01941.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1572-0241.2000.01941.x</ArticleId><ArticleId IdType="pubmed">10763950</ArticleId></ArticleIdList></Reference><Reference><Citation>Rezazadegan M, Shahdadian F, Soheilipour M, et al. Zinc nutritional status, mood states and quality of life in diarrhea-predominant irritable bowel syndrome: a case-control study. Sci Rep. 2022;12:11002. doi: 10.1038/s41598-022-15080-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-15080-2</ArticleId><ArticleId IdType="pmc">PMC9243013</ArticleId><ArticleId IdType="pubmed">35768522</ArticleId></ArticleIdList></Reference><Reference><Citation>Craig CL, Marshall AL, Sj&#xf6;str&#xf6;m M, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35:1381&#x2013;95. doi: 10.1249/01.MSS.0000078924.61453.FB.</Citation><ArticleIdList><ArticleId IdType="doi">10.1249/01.MSS.0000078924.61453.FB</ArticleId><ArticleId IdType="pubmed">12900694</ArticleId></ArticleIdList></Reference><Reference><Citation>Moghaddam MB, Aghdam FB, Jafarabadi MA, et al. The Iranian Version of International Physical Activity Questionnaire (IPAQ) in Iran: content and construct validity, factor structure, internal consistency and stability. World Appl Sci J. 2012;18:1073&#x2013;80. doi: 10.5829/idosi.wasj.2012.18.08.754.</Citation><ArticleIdList><ArticleId IdType="doi">10.5829/idosi.wasj.2012.18.08.754</ArticleId></ArticleIdList></Reference><Reference><Citation>Gentscheva G, Nikolova K, Panayotova V, et al. Application of Arthrospira platensis for Medicinal Purposes and the Food Industry: A Review of the Literature. Life (Basel) 2023;13:845. doi: 10.3390/life13030845.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life13030845</ArticleId><ArticleId IdType="pmc">PMC10058336</ArticleId><ArticleId IdType="pubmed">36984000</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;-Quijal FJ, Ramon-Mascarell F, Pallar&#xe9;s N, et al. Extraction of antioxidant compounds and pigments from spirulina (arthrospira platensis) assisted by pulsed electric fields and the binary mixture of organic solvents and water. Appl Sci (Basel) 2021;11:7629. doi: 10.3390/app11167629.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/app11167629</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhat VB, Madyastha KM. C-phycocyanin: a potent peroxyl radical scavenger in vivo and in vitro. Biochem Biophys Res Commun. 2000;275:20&#x2013;5. doi: 10.1006/bbrc.2000.3270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/bbrc.2000.3270</ArticleId><ArticleId IdType="pubmed">10944434</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Mart&#xed;nez D, Rup&#xe9;rez FJ, Ugarte P, et al. Tocopherol fate in plasma and liver of streptozotocin-treated rats that orally received antioxidants and Spirulina extracts. Int J Vitam Nutr Res. 2007;77:263&#x2013;71. doi: 10.1024/0300-9831.77.4.263.</Citation><ArticleIdList><ArticleId IdType="doi">10.1024/0300-9831.77.4.263</ArticleId><ArticleId IdType="pubmed">18271281</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>